Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$64.8M
201M shares
52-week range
$0.26 – $12.54
1% from low
Exchange
NASDAQ
CS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22.5M | $50.4M | $46.1M | $50.0M | $57.1M | $64.9M | $46.5M | $25.1M |
| Cost of revenue | $19.2M | $42.2M | $36.4M | $42.5M | $51.5M | $58.6M | $44.7M | $21.0M |
| Gross profit | $3.4M | $8.1M | $9.7M | $7.5M | $5.6M | $6.2M | $1.8M | $4.1M |
| Gross margin | 15.0% | 16.1% | 21.0% | 15.1% | 9.9% | 9.6% | 3.8% | 16.4% |
| R&D | $0 | $0 | $0 | $0 | $0 | $1.2M | $568.5K | $1.4M |
| Operating income | $1.1M | $6.0M | $6.2M | $4.8M | $2.4M | $2.1M | −$2.6M | −$563.8K |
| EBITDA | $3.4M | $7.6M | $8.4M | $7.2M | $4.2M | $3.7M | −$1.3M | $879.9K |
| Net income | $1.4M | $5.2M | $5.3M | $5.1M | $3.2M | $1.1M | −$7.8M | −$1.4M |
| Net margin | 6.3% | 10.3% | 11.6% | 10.1% | 5.5% | 1.7% | -16.7% | -5.7% |
| EPS (diluted) | 0.20 | 0.74 | 0.76 | 0.72 | 0.45 | 0.15 | -1.08 | -0.20 |
Annual figures · source: Financial Modeling Prep
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
www.bgmgroupltd.comNo one on the platform currently holds BGM.
No tracked institution reports a position in BGM as of their last filing.
No one on the platform has traded BGM yet.
| $4.5B |
| — |
| GPCRStructure Therapeutics Inc. | $49.71 | +3.03% | $2.9B | — |
| MESOMesoblast Limited | $13.19 | -9.03% | $1.7B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$BGM looks interesting. BGM surges ~20% on momentum following $12M private placement close despite dilution
View on StockTwits ↗@Stock_Mama_Suz I just keep spotting it. $BGM chart is only alive by 1700 share trades in and out. the scanner picked it up only for me to see the likely bot pattern is almost the only thing happening. Hope you find right one and make some money today!
View on StockTwits ↗$BGM "On May 15, 2026, BGM Group Ltd (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain investors (the “Investors”) for a private placement (the “Private Placement”) of 200,000,000 Class A ordinary shares of par value US$0.00833335 per share (the “Class A Ordinary Shares”) at the subscription price of US$0.06 per Class A Ordinary Share (the “Per Share Purchase Price”) and warrants to purchase up to an aggregate of 200,000,000 Class A Ordinary Shares (the “Warrants”)." Warrants exercisable after 90 days, so I wonder what will happen here. I dont see RS approved and this thing can move on air so I bought some, why not.
View on StockTwits ↗$ELAB $TRNR $BGM $VITL ⚡️WHAT DID I SAY??!⚡️ >>> ELAB AND BGM LEADING >> >> GREAT SETUPS ON ALL! << >>>>>>> LISTEN! <<<<<<
View on StockTwits ↗$BGM this stock will dump then will do RS… heavy dilution going on ..
View on StockTwits ↗$BGM Bgm group ✅️ BUY ZONE 0.29 to 0.27 ✋️ RISK BELOW 0.22 🎯 PT. 0.33 0.40 0.53 0.63 0.69 + UP Follow for more
View on StockTwits ↗$BGM it will be delisted or something, -30% daily is not normal. It must be a scam
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.